January 2025 FDA Recall Potassium Chloride by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories
D-0221-2025 - Failed Dissolution Specifications.

This Class II drug recall was voluntarily initiated by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories on January 30, 2025 for the product Potassium Chloride. The FDA reported the reason for recall as failed dissolution specifications.. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0221-2025

Reason for Recall
Failed Dissolution Specifications.
Initiated
01-30-2025
Reported
02-12-2025
Quantity
6997 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Nationwide in the USA
Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters), Rx Only, Distributed by: Aurobindo Pharma USA< INC., 279 Princeton-Hightstown Road, East Windsor, NJ 08520. Made in India. Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152. NDC: 0904-7216-61

Batch or Lot Expiration Information

Lot# T05224; Exp. 02/2026

Affected Packages Involved in this Recall